THE EFFECT OF BORTEZOMIB ON DIFFERENT CELL SUBSETS: AN APPROACH FOR AN INDIVIDUAL PERSONALIZED MEDICINE

被引：0

作者：

Primo, D. ^{[1
]}

Gorrochategui, J. ^{[1
]}

Robles, A. ^{[1
]}

San Miguel, J. ^{[2
]}

Oriol, A. ^{[3
]}

Lahuerta Palacios, J. J. ^{[4
]}

Diaz Mediavilla, J. ^{[5
]}

Bailen, A. ^{[6
]}

Cordoba Mascunano, R. ^{[7
]}

Moreno Belmonte, M. J. ^{[8
]}

Martin Sanchez, J. ^{[9
]}

Hernandez Martin, J. M. ^{[10
]}

Chinea, A. ^{[11
]}

Palomera Bernal, L. ^{[12
]}

Gonzalez Montes, Y. ^{[13
]}

Prosper Cardoso, F. ^{[2
]}

Iglesias del Barrio, R. ^{[14
]}

Echeveste, A. ^{[15
]}

Hernandez Garcia, M. T. ^{[16
]}

Encinas, C. ^{[17
]}

Perez de Oteyza, J. ^{[18
]}

Gomez, C. ^{[1
]}

Gaspar, M. ^{[1
]}

Ballesteros, J. ^{[1
]}

Hernandez-Campo, P. ^{[1
]}

Ocio, E. M. ^{[19
]}

Martinez-Lopez, J. ^{[20
]}

机构：

[1] Vivia Biotech, Madrid, Spain

[2] Univ Navarra Clin, Navarra, Spain

[3] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain

[4] Hosp Univ Doce Octubre, Madrid, Spain

[5] Hosp Clin San Carlos, Madrid, Spain

[6] Hosp Reg Univ Carlos Haya, Malaga, Spain

[7] Hosp Univ Infanta Sofia, Madrid, Spain

[8] Hosp Gen Univ Morales Meseguer, Murcia, Spain

[9] Hosp Univ Virgen del Rocio, Seville, Spain

[10] Hosp Gen Segovia, Segovia, Spain

[11] Hosp Univ Ramon y Cajal, Madrid, Spain

[12] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain

[13] Hosp Univ Girona Dr Josep Trueta, Girona, Spain

[14] MD Anderson Canc Ctr Madrid, Madrid, Spain

[15] Hosp Univ Donostia, Guipuzcoa, Spain

[16] Hosp Univ Canarias, Tenerife, Spain

[17] Hosp Gen Univ Gregorio Maranon, Madrid, Spain

[18] HM Univ Sanchinarro, Madrid, Spain

[19] Hosp Clin Univ Salamanca, Salamanca, Spain

[20] Hosp Doce Octubre, Madrid, Spain

来源：

HAEMATOLOGICA | 2014年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P334

引用

页码：97 / 98

页数：2

共 50 条

[21] Network Integration Approach for Personalized Medicine
Gangopadhyay, A.
Odebode, I
Anam, A.
PROCEEDINGS OF THE 2ND INTERNATIONAL CONGRESS ON PERSONALIZED MEDICINE (UPCP 2013), 2014, : 35 - 39
[22] Personalized medicine: A transformative approach is needed
Hudson, Thomas J.
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 180 (09) : 911 - 913
[23] A PERSONALIZED MEDICINE APPROACH TO ALCOHOLISM TREATMENT
O'Brien, Charles P.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 12A - 12A
[24] Reprogrammed cell delivery for personalized medicine
Wieland, Markus
Fussenegger, Martin
ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (13) : 1477 - 1487
[25] The cell secretome in personalized and regenerative medicine
Salgado, Antonio J.
Gimble, Jeffrey M.
Costa, Bruno M.
BIOCHIMIE, 2018, 155 : 1 - 1
[26] Towards personalized medicine: exploring the consequences of the effect model-based approach
Boissel, Jean-Pierre
Kahoul, Riad
Amsallem, Emmanuel
Gueyffier, Francois
Haugh, Margaret
Boissel, Francois-Henri
PERSONALIZED MEDICINE, 2011, 8 (05) : 581 - 586
[27] Different perspectives on translational genomics in personalized medicine
Dogan, Berkcan
Celik, Hale Goksever
Kucukkaya, Reyhan Diz
Acar, Ece Gumusoglu
Gunel, Tuba
JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2022, 23 (04) : 314 - 321
[28] Hematopoietic stem cell transplantation (HSCT) as an example of personalized approach in the management of individual disease
Hele Everaus
EPMA Journal, 2014, 5 (Suppl 1):
[29] Personalized medicine in nephrology: a novel approach or just good medicine?
Taal, Maarten W.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2018, 27 (06): : 395 - 397
[30] In-vitro effect of pembrolizumab on different T regulatory cell subsets
Toor, S. M.
Khaja, A. S. Syed
Alkurd, I.
Elkord, E.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 191 (02): : 189 - 197

← 1 2 3 4 5 →